BMS tops list of sustainability stars

Four pharmaceutical companies have exceeded the 50 percent mark in an analysis of the voluntary sustainability reporting. Bristol-Myers Squibb, Sanofi-Aventis, Abbott Labs and Johnson & Johnson took top honors among Fortune 500 pharmaceutical companies.

Lowest scores went to Forest Labs, NBTY and King Pharmaceuticals. The analysis was done by the Roberts Environmental Center (REC) at Claremont McKenna College.

The analysis combines environmental and social reports under the heading of sustainability. The top scorers, according to the report, provide extensive reports and Internet pages detailing the company's impact, vision, programs and goals. Those with the lowest scores rarely mention corporate responsibility.

The pharma industry, like most others, did the least reporting on environmental performance.

- here's the report

Suggested Articles

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.